Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow ACCURAY INC

Get SEC filing alerts via email and in your feed for ACCURAY INC

ARAY

ACCURAY INC

About ACCURAY INC

Accuray Incorporated is a radiation therapy company specializing in advanced treatment solutions for cancer and other disorders. Its key products, including the CyberKnife and TomoTherapy platforms, utilize innovative technologies like AI-driven motion tracking for precise, personalized treatments. With a focus on enhancing patient care and expanding market reach, Accuray targets healthcare providers globally, aiming to improve treatment efficiency and outcomes while addressing significant unmet needs in oncology.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from ACCURAY INC

1
1
ACCURAY INC Accuray Reports 7% Revenue Decline in Q3 Fiscal Year 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
ACCURAY INC Accuray Reports 12% Revenue Decline and $13.8 Million Net Loss in Q2 FY26

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
ACCURAY INC Accuray Reports $93.9 Million Revenue, Net Loss of $21.7 Million for Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
ACCURAY INC Accuray Reports 3% Revenue Growth to $458.5 Million for Fiscal Year Ending June 30, 2025

Via official filing (AI summary) | 9 months ago | 0 comments

5
1
ACCURAY INC Accuray Reports 12% Revenue Growth in Q3 Fiscal Year 2025, Despite Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
ACCURAY INC Accuray Reports 8% Revenue Growth to $116.2 Million in Q2 FY 2025

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
ACCURAY INC Accuray Reports 2% Revenue Decline, Net Loss in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments